Results 111 to 120 of about 6,120 (213)

Terapèutica antiparasitària [PDF]

, 2005
Els paràsits són els més oblidats dels microorganismes patògens. El fet que la seva major prevalença es doni als països de l'àrea tropical, països pobres en la seva major part, potser influeix en aquest fet.
Oliveira, Inés M.
core  

Mass administration of an antimalarial drug combining 4-aminoquinoline and 8-aminoquinoline in Tanganyika.

Bulletin of the World Health Organization, 1998
For the eradication of malaria from hyperendemic regions of tropical Africa it is apparent that use may have to be made of antimalarial drugs, administered individually on a census basis, in addition to measures directed against the mosquito. The suppressive activity of existing compounds among individuals having different degrees of immunity is well ...
openaire   +1 more source

Are basic and lipophilic chain groups highly required in leishmanicidal quinolines to favor the phagolysosome accumulation? [PDF]

Front Chem
Romero AH.
europepmc   +1 more source

Identifying Drugs Associated With Parkinson's Disease Risk Using Machine Learning. [PDF]

Basic Clin Pharmacol Toxicol
Pylkkö E, Courtois É, Paakinaho A, Hartikainen S, Kaasinen V, Elbaz A, Thiébaut ACM, Ahmed I, Tolppanen AM.   +8 more
europepmc   +1 more source

<i>In vitro</i> and <i>in vivo</i> studies of dehydroxylated-isoquines and -isotebuquines against trypanosomatids: a preclinical drug candidate for treatment of cutaneous leishmaniasis. [PDF]

RSC Med Chem
Romero AH, Serna E, Aguilera E, Davila B, Delgado F, Scalese G, Pérez-Díaz L, Yaluff G, Rodríguez N, Cerecetto H.   +9 more
europepmc   +1 more source

The Deanes' malarias and the antimalarial drugs in 1939 and the 1940s. [PDF]

Mem Inst Oswaldo Cruz
Paumgartten FJR, de Oliveira ACAX, Daniel-Ribeiro CT.   +2 more
europepmc   +1 more source

Designing novel bisquinoline antimalarials from historical 4-aminoquinolines to combat drug-resistant malaria. [PDF]

Antimicrob Agents Chemother
Handford MJ, Li Y, Riscoe T, Zhang X, Kelly JX, Riscoe MK.   +5 more
europepmc   +1 more source

Editorial: Quinoline as lead structures for the development of leishmanicidal agents. [PDF]

Front Chem
Romero AH, Benaim G.
europepmc   +1 more source

Investigation of the activity of 4-aminoquinolines as cysteine protease inhibitors with application in the treatment of Chagas disease. [PDF]

Mem Inst Oswaldo Cruz
Sheu-Idrees R, Marques GVL, Santana PAL, Diniz LA, Resende DM, Odoma S, Olorunshola O, Ferreira RS, Murta SMF, Maltarollo VG, de Oliveira RB.   +10 more
europepmc   +1 more source

Fractional curative killing of pyronaridine or artesunate combinations with tafenoquine, 4-aminoquinolines, or azithromycin in a murine malaria-luciferase model. [PDF]

Antimicrob Agents Chemother
Lee G, Aneke JS, Sullivan DJ.
europepmc   +1 more source